- Home
- CNK vs SLNO Comparison
CNK vs SLNO Comparison
Compare CNK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNK | SLNO |
|---|---|---|
| Founded | 1984 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CNK | SLNO |
|---|---|---|
| Price | $23.11 | $43.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $33.09 | ★ $112.70 |
| AVG Volume (30 Days) | ★ 2.8M | 1.6M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $3,153,000,000.00 | $98,675,000.00 |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $8.48 | $156.76 |
| P/E Ratio | $21.25 | ★ N/A |
| Revenue Growth | ★ 9.70 | N/A |
| 52 Week Low | $21.60 | $39.43 |
| 52 Week High | $34.01 | $90.32 |
Technical Indicators
Market Signals| Indicator | CNK | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 40.88 |
| Support Level | $23.57 | $41.34 |
| Resistance Level | $24.81 | $44.50 |
| Average True Range (ATR) | 0.97 | 2.65 |
| MACD | 0.11 | 0.20 |
| Stochastic Oscillator | 36.98 | 31.27 |
Price Performance
Historical ComparisonAbout CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.